NDC 82009-112 – Capecitabine
Capecitabine 500 mg/1 · Tablet · Oral
Product NDC82009-112
Product details
- Brand name
- Capecitabine
- Generic name
- Capecitabine
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA204345
- Marketed since
- July 21, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Nucleoside Metabolic Inhibitor
Active ingredients
- Capecitabine 500 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 82009-112-12 | 120 TABLET in 1 BOTTLE (82009-112-12) | Jul 21, 2023 |
Other Capecitabine products
- 59651-204 Capecitabine 150 mg/1 · Tablet · Aurobindo Pharma Limited
- 59651-205 Capecitabine 500 mg/1 · Tablet · Aurobindo Pharma Limited
- 55111-496 Capecitabine 150 mg/1 · Tablet · Dr. Reddy's Laboratories Limited
- 55111-497 Capecitabine 500 mg/1 · Tablet · Dr. Reddy's Laboratories Limited
- 16729-072 Capecitabine 150 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 16729-073 Capecitabine 500 mg/1 · Tablet, Film Coated · Accord Healthcare Inc.
- 60687-149 Capecitabine 500 mg/1 · Tablet, Film Coated · American Health Packaging
- 67877-458 Capecitabine 150 mg/1 · Tablet, Film Coated · Ascend Laboratories, LLC
- 67877-459 Capecitabine 500 mg/1 · Tablet, Film Coated · Ascend Laboratories, LLC
- 68001-643 Capecitabine 150 mg/1 · Tablet, Film Coated · BluePoint Laboratories
- 68001-488 Capecitabine 500 mg/1 · Tablet, Film Coated · BluePoint Laboratories
- 68001-487 Capecitabine 150 mg/1 · Tablet, Film Coated · BluePoint Laboratories